Evidence map›Paper›PMID 40073865›Full record

ArticleCell genomics2025

Proteome-wide assessment of differential missense variant clustering in neurodevelopmental disorders and cancer.

Jeffrey K Ng, Yilin Chen, Titilope M Akinwe, Hillary B Heins, Elvisa Mehinovic, Yoonhoo Chang, David H Gutmann, Christina A Gurnett, Zachary L Payne, Juana G Manuel and 2 more

Abstract read
In one paragraph

Article in Cell genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jeffrey K NgDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Yilin ChenDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21205, USA.
Titilope M AkinweDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; Molecular Genetics & Genomics Graduate Program, Washington University School of Medicine, St. Louis, MO 63110, USA.
Hillary B HeinsDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Elvisa MehinovicDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Yoonhoo ChangDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; Human & Statistical Genetics Graduate Program, Washington University School of Medicine, St. Louis, MO 63110, USA.
David H GutmannDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Christina A GurnettDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA.
Zachary L PayneDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; Molecular Genetics & Genomics Graduate Program, Washington University School of Medicine, St. Louis, MO 63110, USA.
Juana G ManuelDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Rachel KarchinDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21205, USA; Department of Computer Science, Johns Hopkins University, Baltimore, MD 21205, USA; The Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA; Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD 21205, USA. Electronic address: karchin@jhu.edu.
Tychele N TurnerDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: tychele@wustl.edu.

Funding

WUIDDRC Supplement-Supporting the health and well-being of children with intellectual and developmental disability during COVID-19 pandemicP50HD103525 · NICHD · WASHINGTON UNIVERSITY · PI JEFFREY D MILBRANDT · 2020 to 2026
$15.5M
Noncoding mutations in neurodevelopmental disordersR01MH126933 · NIMH · WASHINGTON UNIVERSITY · PI Tychele Naomi Turner · 2022 to 2026
$3.6M
OpenCRAVAT: Informatics Tools for High-Throughput Analysis of Cancer MutationsU24CA258393 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rachel Karchin · 2022 to 2026
$3.3M
Nature and contribution of noncoding, regulatory mutations in neurodevelopmental disordersR00MH117165 · NIMH · WASHINGTON UNIVERSITY · PI TURNER, TYCHELE NAOMI · 2019 to 2021
$743k
NCI NIH HHS U24 CA258393NICHD NIH HHS P50 HD103525NIMH NIH HHS R00 MH117165NIMH NIH HHS R01 MH126933
6 · The paper itself

Abstract

Prior studies examining genomic variants suggest that some proteins contribute to both neurodevelopmental disorders (NDDs) and cancer. While there are several potential etiologies, here, we hypothesize that missense variation in proteins occurs in different clustering patterns, resulting in distinct phenotypic outcomes. This concept was first explored in 1D protein space and expanded using 3D protein structure models. Missense de novo variants were examined from 39,883 families with NDDs and missense somatic variants from 10,543 sequenced tumors covering five The Cancer Genome Atlas (TCGA) cancer types and two Catalog of Somatic Mutations in Cancer (COSMIC) pan-cancer aggregates of tissue types. We find 18 proteins with differential missense variation clustering in NDDs compared to cancers and 19 in cancers relative to NDDs. These proteins may be important for detailed assessments in thinking of future prognostic and therapeutic applications. We establish a framework for interpreting missense patterns in NDDs and cancer, using advances in 3D protein structure prediction.

Indexed as

Mutation, MissenseNeoplasmsNeurodevelopmental DisordersProteomeCluster AnalysisHumansProteome3D protein structure modelscancerclustering algorithmde novomissenseneurodevelopmental disordersproteinsomaticvariant interpretation

Identifiers

PMID40073865
PMCPMC12008811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.